Burzynski Research Institute, Inc. Stock Other OTC
Equities
BZYR
US1231591058
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.83M 6.59M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 3.38K 4.61K | Net cash position 2023 | 934 1.27K | EV / Sales 2023 | - |
P/E ratio 2022 |
-3
x | P/E ratio 2023 |
-3.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 83-12-31 | |
Director of Finance/CFO | 46 | 12-02-29 | |
Tomasz Janicki
PRN | Corporate Officer/Principal | 58 | 12-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 83-12-31 | |
Director/Board Member | 44 | 11-09-07 | |
Director/Board Member | 60 | 21-10-05 |
1st Jan change | Capi. | |
---|---|---|
+29.31% | 48.16B | |
-0.58% | 41.73B | |
+43.74% | 41.03B | |
-5.31% | 28.77B | |
+10.93% | 25.59B | |
-21.97% | 18.96B | |
+8.31% | 12.92B | |
+27.13% | 12.03B | |
-3.20% | 11.77B |